Corcept Therapeutics stock plunges after loss in patent battle with with Teva Markets January 2, 2024 [ad_1] Dr_Microbe/iStock through Getty Photos Corcept Therapeutics (NASDAQ:CORT) plummeted 38% in after-hours buying and selling on Friday after a loss…
Corcept loses patent spat against Teva, shares tumble By Reuters Finances December 30, 2023 [ad_1] © Reuters. FILE PHOTO: The emblem of Teva Pharmaceutical Industries is seen in Tel Aviv, Israel February 19, 2019.…
